A Method of Treating Depression by Immune Modulation
OwnerWilfred Jefferiesinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of immune modulation. In particular, the present invention relates to regulation of neuroinflammation by modulation of ABCF1. Modulation of ABCF1 may be useful in the MDD.
Claims18
A method of inhibiting neuroinflammation in a patient in need thereof, said method comprising administering an agonist of ABCF1.
A method inhibiting neuroinflammation in a patient in need thereof, said method comprising administering an ABCF1 protein or a polynucleotide encoding ABCF1.
A method of preventing and/or treating Major Depressive Disorder, said method comprising administering an agonist of ABCF1.
A method of preventing and/or treating Major Depressive Disorder, said method comprising administering an ABCF1 protein or a polynucleotide encoding ABCF1.
A method of treating an autoimmune disease and comorbid neuropsychiatric disorders, said method comprising administering an agonist of ABCF1.
A method of treating an autoimmune disease and comorbid neuropsychiatric disorders, said method comprising administering an ABCF1 protein or a polynucleotide encoding ABCF1.
A method of preventing and/or treating a depressive disorder associated with inflammation, said method comprising administering an agonist of ABCF1.
Dependencies are inferred from the claim text.